van Dalfsen JH
Department of Psychiatry, University Medical Center Groningen, Groningen, the Netherlands.
ArticleKetamine
Default mode network functional connectivity following treatment with conventional antidepressants and (es)ketamine in major depressive disorder: A systematic review.
ArticleKetamine
Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.
ArticleKetamine
Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.
ArticleKetamine
Effects of ketamine on sleep and circadian rhythmicity in major depressive disorder and bipolar disorder: A systematic review.
ArticleKetamine
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
ArticleKetamine
ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.
ArticleKetamine
The Ketamine Trial for Acute Suicidality (KETA): Study Protocol of a Double-Blind Randomized Placebo-Controlled Superiority Trial on Intranasal Racemic Ketamine Compared to the Active Placebo Intranasal Midazolam as Treatment for Acute Suicidality.
ArticlePsilocybin
Concomitant use of antidepressants and classic psychedelics: A scoping review.
ArticleKetamine
The Association between Intranasal Esketamine and Treatment-emergent Insomnia in the Treatment of Treatment-resistant Major Depression: A Meta-analysis.
ArticlePsilocybin
Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.
ArticleKetamine